Hyperammonemic encephalopathy induced by valproic acid

被引：0

作者：

Zhu, Qiuyu M. ^{[1
]}

Singh, Amitosh K. ^{[1
]}

Chang, Huai-En Rachel ^{[1
]}

Konka, Sandeep A. ^{[2
]}

机构：

[1] Kaiser Permanente Mid Atlantic States, Internal Med, Gaithersburg, MD 20879 USA

[2] Mid Atlantic Permanente Med Grp, Hosp Med, Rockville, MD USA

来源：

BMJ CASE REPORTS | 2024年 / 17卷 / 02期

关键词：

Unwanted effects; adverse reactions; Safety; Psychiatry (drugs and medicines); Healthcare improvement and patient safety; Drugs: CNS (not psychiatric); RISK-FACTORS; CARNITINE; LORAZEPAM;

D O I：

10.1136/bcr-2023-257144

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Valproate (VPA) is broad-spectrum antiepileptic drug. Several adverse reactions including hepatotoxicity, fetal risk and pancreatitis are well known and labelled as boxed warnings in the USA. One adverse reaction that is less well known but clinically significant for its severe morbidity is hyperammonemic encephalopathy. We present a case of woman with hyperammonemic encephalopathy following the initiation of VPA therapy; she had a favourable outcome with discontinuation of the drug and prompt treatment with lactulose and L-carnitine.

引用

页数：4

共 50 条

[31] Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting
Kimmel, RJ
Irwin, SA
Meyer, JM
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (01) : 57 - 58
[32] Topiramate/valproic acid interactionHypoxic respiratory failure secondary to hyperammonemic encephalopathy: case report
Reactions Weekly, 2018, 1710 (1) : 297 - 297
[33] Valproic acid-induced hyperammonemic encephalopathy (VIHE) in a patient with Bipolar disorder: A case report and literature review.
Isidahome, E.
Gabriel, M. San
EUROPEAN PSYCHIATRY, 2022, 65 : S346 - S346
[34] VALPROIC-INDUCED HYPERAMMONEMIC ENCEPHALOPATHY AGGRAVATED BY COMBINED USE OF TOPIRAMATE - A CASE REPORT
Zhao, Ke
Lv, Dian
Chen, Miao
Yang, Yue
PSYCHIATRIA DANUBINA, 2021, 33 (02) : 182 - 184
[35] Valproate induced hyperammonemic encephalopathy
Mehndiratta, MM
Gupta, S
Khwaja, GA
Singh, G
Satyawani, M
EPILEPSIA, 2004, 45 : 133 - 133
[36] Hyperammonemia and valproic acid-induced encephalopathy
Modjtahedi, Bobeck
Xiong, Glen L.
AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (12): : 1912 - 1913
[37] Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature
Raru, Yonas
Zeid, Fuad
RESPIRATORY MEDICINE CASE REPORTS, 2018, 25 : 1 - 3
[38] Case Report: A Case of Valproic Acid-Induced Hyperammonemic Encephalopathy Associated With the Initiation of Lithium: A Re-duplicable Finding
Levy, Anna
Very, Etienne
Montastruc, Francois
Birmes, Philippe
Jullien, Adeline
Richaud, Louis
FRONTIERS IN PSYCHIATRY, 2022, 13
[39] Treatment of valproic acid-induced encephalopathy with carbalagenic acid
Avila-Cabreja, Jose A.
Fornaris-Cedeno, Yasmany
Fernandez-Massip, Haydee
Sosa-Gonzalez, Ismael
REVISTA DE NEUROLOGIA, 2018, 66 (04) : 135 - 136
[40] Hyperammonemic encephalopathy associated with valproate acid
Osuna, MT
Burcet, J
Ramió, L
Ustrell, X
Silva, Y
Molins, A
NEUROLOGIA, 2003, 18 (06): : 347 - 350

← 1 2 3 4 5 →